BEUDAMED
    FDA Adverse Event Injury Summary report: N

    AMPLATZER AMULET

    MDR report key: 25049727 · Received April 30, 2026

    Report

    Report Number
    2135147-2026-02865
    Event Type
    Injury
    Date Received
    April 30, 2026
    Date of Event
    June 18, 2025
    Report Date
    April 30, 2026
    Manufacturer
    ABBOTT MEDICAL
    Product Code
    NGV
    PMA / PMN Number
    P200049
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    US
    Reporter Occupation
    OTHER

    Narratives

    Additional Manufacturer Narrative · 0

    ONE LEFT ATRIAL APPENDAGE OCCLUSION REINTERVENTION EVENTS WERE REPORTED IN THE CURRENT REPORTING PERIOD. A MORE COMPREHENSIVE ASSESSMENT COULD NOT BE PERFORMED AS LIMITED INFORMATION WAS PROVIDED INCLUDING THAT THE DEVICE WAS NOT RETURNED FOR ANALYSIS. BASED ON THE LIMITED INFORMATION RECEIVED, THE CAUSE OF THE REPORTED INCIDENT COULD NOT BE CONCLUSIVELY DETERMINED. HOWEVER, RISK ASSESSMENT WAS COMPLETED FOR THE REPORTED INCIDENTS 29 OUT OF 12,215 (0.24%) SUBJECTS EXPERIENCED LEFT ATRIAL APPENDAGE OCCLUSION REINTERVENTION SINCE THE BEGINNING OF THE REGISTRY. THE ADVERSE EVENTS AND RATES REPORTED IN THIS STUDY WERE FOUND TO BE ANTICIPATED IN THE STUDY POPULATION AND ARE IN ALIGNMENT WITH RATES OBSERVED IN OTHER CLINICAL STUDIES. NO NEW RISKS HAVE BEEN IDENTIFIED FOR THIS POPULATION. NO NEW HAZARDS OR HARMS WERE IDENTIFIED THAT WOULD IMPACT THE BENEFIT/RISK PROFILE. BASED ON A REVIEW OF THE AVAILABLE INFORMATION, THERE WAS NO INDICATION OF A PRODUCT QUALITY ISSUE WITH REGARDS TO MANUFACTURE, DESIGN, OR LABELING. THEREFORE, NO REMEDIAL ACTION IS REQUIRED AT THIS TIME. THIS REPORT IS FOR QUARTER 1 TIMEFRAME BETWEEN 01 JANUARY 2026 - 31 MARCH 2026. D4. PRIMARY UDI NUMBER: THE UDI NUMBER IS NOT KNOWN AS THE PART AND LOT NUMBER WERE NOT PROVIDED.

    Description of Event or Problem · 0

    IT WAS REPORTED THROUGH AMULET LAAO REGISTRY DATA THAT AMPLATZER AMULET DEVICES MAY BE RELATED TO 1 LEFT ATRIAL APPENDAGE OCCLUSION REINTERVENTION ADVERSE EVENT WHICH IS CONSIDERED SERIOUS INJURY. THE RELATIONSHIP OF THE ADVERSE EVENTS TO THE AMPLATZER AMULET DEVICES COULD NOT BE DETERMINED BASED ON THE LIMITED DATA RECEIVED FROM THE REGISTRY. AMULET LAAO REGISTRY DATA IS REPORTED AS A SUMMARY PER SUMMARY REPORTING EXEMPTION APPROVAL NUMBER - GEN2201026. THE DATA RECEIVED INDICATED THAT THE PROCEDURE DATE WAS 29 NOVEMBER 2023. PATIENT 79 YEARS OLD. PATIENT WAS A MALE. THIS REPORT IS FOR QUARTER 1 TIMEFRAME BETWEEN 01 JANUARY 2026 - 31 MARCH 2026. AS OF 20 MARCH 2026, 12,215 PATIENTS WERE TREATED WITH THE AMULET DEVICE.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    385915 AMPLATZER AMULET CARDIAC PLUG NGV ABBOTT MEDICAL UNK AMPLATZER AMULET

    Patients

    Seq Age Sex Outcome Treatment
    1 79 YR Male Required Intervention